SYNERGY PHARMACEUTICALS
Synergy Pharmaceuticals Inc., headquartered in New York, NY with laboratories in Doylestown, PA, is a biopharmaceutical company focused on the research and development of novel therapies for the treatment of chronic idiopathic constipation, irritable bowel syndrome with constipation and other difficult-to-treat gastrointestinal (GI) conditions. Synergy’s lead drug, plecanatide, and next-generation candidate, SP-333, are proprietary analogs of the natural human GI hormone, uroguanylin, and members of the new class of guanylate cyclase-C (“GC-C”) agonists.
SYNERGY PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
1992-02-11
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.synergypharma.com
Total Employee:
101+
Status:
Active
Contact:
212-297-0020
Email Addresses:
[email protected]
Total Funding:
407.23 M USD
Technology used in webpage:
Domain Not Resolving Euro IPv6 Yoast WordPress SEO Plugin Yoast Plugins Yoast SEO Premium Facebook Sharer Contact Form 7 WordPress 6.4 Microsoft
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Repligen
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Post-IPO Debt - Synergy Pharmaceuticals
Official Site Inspections
http://www.synergypharma.com
- Host name: bscofficespace.com
- IP address: 108.167.182.25
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Synergy Pharmaceuticals"
Synergy Pharmaceuticals LLC - Drug pipelines, Patents, Clinical …
Www.synergypharma.com. Public Company | Subsidiary Company | 1992 | New York, United States | 100-250 | OTC: SGYPQ | www.synergypharma.com. Last update 01 Nov 2024. …See details»
SYNERGY PHARMA - LinkedIn
Synergy Pharma redefines excellence in continuing education and support for healthcare and sales professionals. With in-depth expertise in the pharmaceutical sector, we are much more …See details»
Synergy Pharmaceuticals Announces Agreement for Bausch Health …
NEW YORK, Dec. 12, 2018 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and …See details»
Synergy Pharmaceuticals - Craft
Apr 10, 2019 New York, NY HQ. United States. 420 Lexington Ave #2012. Doylestown, PA. United States. 3805 Old Easton Rd. Wayne, PA. United States. 480 Swedesford RdSee details»
Synergy Pharmaceuticals LLC - Company Profile and News
Company profile page for Synergy Pharmaceuticals LLC including stock price, company news, executives, board members, and contact informationSee details»
Overview, News & Similar companies - ZoomInfo.com
Mar 5, 2018 Synergy Pharmaceuticals contact info: Phone number: (212) 297-0020 Website: www.synergypharma.com What does Synergy Pharmaceuticals do? Synergy Pharmaceuticals …See details»
Synergy Pharmaceuticals Appoints Troy Hamilton Chief Executive …
Dec 19, 2017 Synergy Pharmaceuticals Inc. Gem Hopkins, 212-584-7610 VP, Investor Relations and Corporate Communications [email protected] Release Summary Synergy …See details»
Synergypharma - Crunchbase Company Profile & Funding
Organization. Synergypharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Synergypharma is located in Udine, Friuli-Venezia Giulia, Italy. …See details»
Synergy Pharmaceuticals CEO and Key Executive Team - Craft
Synergy Pharmaceuticals's Director and Chief Executive Officer is Pharm.D Troy Hamilton. Other executives include Patrick Griffin, Executive Vice President and Chief Medical Officer; Gary G. …See details»
Synergy Pharma - Company Information, Competitors, News
Find useful insights on Synergy Pharma's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Synergy Pharma.See details»
Working At Synergy Pharma: Company Overview and Culture
Www.synergypharma.com. Organization Type. Public. Social Media. Synergy Pharmaceuticals Inc., headquartered in New York, NY with laboratories in Doylestown, PA, is a …See details»
Synergy Pharmaceuticals Announces Completion of Sale to Bausch …
NEW YORK, March 6, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and …See details»
Synergy Pharmaceuticals, Inc. [SGYP] Chairman & CEO to Ring
Mar 15, 2012 [email protected]. NASDAQ MarketSite: Jen Knapp (212) 401-8916. [email protected]. Feed Information: Fiber Line (Encompass …See details»
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to
Feb 28, 2018 For more information, please visit www.synergypharma.com. About Cipher Pharmaceuticals Inc. Cipher (TSX: CPH ) is a specialty pharmaceutical company with a robust …See details»
Synergy Pharmaceuticals to Present at Oppenheimer 27
Mar 14, 2017 For more information, please visit www.synergypharma.com. Contacts Synergy Pharmaceuticals Inc. Gem Hopkins, 212-584-7610 VP, Investor Relations and Corporate …See details»
Synergy Pharma Names New CEO - BioSpace
Dec 19, 2017 Synergy’s proprietary GI platform includes one commercial product TRULANCE (plecanatide) and a second product candidate, dolcanatide. For more information, please visit …See details»
Synergy Pharmaceuticals : Presents Additional Phase 3 Plecanatide …
May 24, 2016 Synergy's proprietary GI platform is based on uroguanylin and includes two lead product candidates - plecanatide and dolcanatide. For more information, please visit …See details»
Synergy Pharmaceuticals : Presents New Plecanatide Phase 3 Data …
May 24, 2016 Synergy's proprietary GI platform is based on uroguanylin and includes two lead product candidates - plecanatide and dolcanatide. For more information, please visit …See details»
Synergy Pharmaceuticals (SGYP) Stock Price, News & Analysis
Nov 24, 2024 www.synergypharma.com. Phone 212-297-0020. Fax N/A. Employees N/A. Year Founded N/A. Profitability. EPS (Most Recent Fiscal Year) ($1.02) Trailing P/E Ratio N/A. …See details»
Synergy Pharmaceuticals Receives Court Approval for the Sale of …
NEW YORK, March 1, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and …See details»